Evidence map›Paper›PMID 23403946›Full record

ReviewAmerican journal of physiology. Endocrinology and metabolism2013

Asparagine synthetase: regulation by cell stress and involvement in tumor biology.

Mukundh N Balasubramanian, Elizabeth A Butterworth, Michael S Kilberg

2 registry-linked trialsAbstract readReview
In one paragraph

Review in American journal of physiology. Endocrinology and metabolism, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 131 papers.

0numbers the graph read from it
0cells of the map it votes in
131citing papers in PubMed
9.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02410902 phase3completednot on this mapstarted 2015, after this paper: background citation

A Double Blind, Randomized, Placebo-Controlled Study of CM-AT for the Treatment of Autism in Children With All Levels of Fecal Chymotrypsin (FCT)

TypeinterventionalSponsorCuremarkRan2015 to 2017Enrolled190ConditionsAutismArmsCM-AT, PLACEBO
NCT02649959 phase3active not recruitingnot on this mapstarted 2015, after this paper: background citation

An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin

TypeinterventionalSponsorCuremarkRan2015 to 2028Enrolled405ConditionsAutismArmsCM-AT
3 · Its place in the literature

Who cites it

131 citing papers in PubMed, 238 citations in OpenAlex.

  1. Article
  2. Article
  3. Glutamine metabolic enzymes: to filament or not to filament?Biochemical Society transactions · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Biomedicines · 2025
    Article
  9. Article
  10. Transcriptional Readthrough atbioRxiv : the preprint server for biology · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Targeting amino acid in tumor therapy.Frontiers in oncology · 2025
    Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

71 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Mukundh N BalasubramanianDepartment of Biochemistry and Molecular Biology, Shands Cancer Center and Center for Nutritional Sciences, University of Florida College of Medicine, Gainesville, FL 32610, USA.
Elizabeth A Butterworth
Michael S Kilberg
University of Florida Health · US

Funding

Amino Acid Regulation of Alternative SplicingR01DK092062 · NIDDK · UNIVERSITY OF FLORIDA · PI KILBERG, MICHAEL S. · 2011 to 2014
$1.3M
Amino Acid Regulation of the Fos/Jun Transcription FactorsR01DK094729 · NIDDK · UNIVERSITY OF FLORIDA · PI KILBERG, MICHAEL S. · 2011 to 2014
$1.2M
NIDDK NIH HHS DK-92062NIDDK NIH HHS DK-94729NIDDK NIH HHS R01 DK092062NIDDK NIH HHS R01 DK094729
6 · The paper itself

Abstract

Asparagine synthetase (ASNS) catalyzes the conversion of aspartate and glutamine to asparagine and glutamate in an ATP-dependent reaction. The enzyme is ubiquitous in its organ distribution in mammals, but basal expression is relatively low in tissues other than the exocrine pancreas. Human ASNS activity is highly regulated in response to cell stress, primarily by increased transcription from a single gene located on chromosome 7. Among the genomic elements that control ASNS transcription is the C/EBP-ATF response element (CARE) within the promoter. Protein limitation or an imbalanced dietary amino acid composition activate the ASNS gene through the amino acid response (AAR), a process that is replicated in cell culture through limitation for any single essential amino acid. Endoplasmic reticulum stress also increases ASNS transcription through the PERK-eIF2-ATF4 arm of the unfolded protein response (UPR). Both the AAR and UPR lead to increased synthesis of ATF4, which binds to the CARE and induces ASNS transcription. Elevated expression of ASNS protein is associated with resistance to asparaginase therapy in childhood acute lymphoblastic leukemia and may be a predictive factor in drug sensitivity for certain solid tumors as well. Activation of the GCN2-eIF2-ATF4 signaling pathway, leading to increased ASNS expression appears to be a component of solid tumor adaptation to nutrient deprivation and/or hypoxia. Identifying the roles of ASNS in fetal development, tissue differentiation, and tumor growth may reveal that ASNS function extends beyond asparagine biosynthesis.

Indexed as

AnimalsAsparagineAspartate-Ammonia LigaseGene Expression Regulation, EnzymologicGene Expression Regulation, NeoplasticHumansNeoplasmsStress, PhysiologicalUnfolded Protein ResponseAsparagineAspartate-Ammonia Ligase

Identifiers

PMID23403946
PMCPMC3625782
OpenAlexW2162438404

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.